What's new in DyslipidemiaLast update of the site: Tuesday, 21 September 2021
Schmitt, Johannes et al. | Nutrition, Metabolism and Cardiovascular...
Glycogen storage disease type I (GSD I) is associated with hyperlipidemia, a known risk factor for premature...
Arrobas Velilla, Teresa et al. | Clinica e investigacion en arteriosclerosis...
Severe hypercholesterolaemia is a major cardiovascular risk factor. Early detection and treatment can...
Dietz Matthieu et al. | EJNMMI Research 2021; 11(1): 71
Cardiovascular atherosclerotic disease is the leading cause of death worldwide [1]. Atherosclerosis is...
Lida Khurrami et al. | Heart 2021; 107(19): 1536-43
Data are available on reasonable request. Study data were collected and managed using REDCap data management,...
Ryan P.
Brady
et al. | Pediatric Diabetes 2021; AOP: 10.1111/pedi.13253...
Type 2 diabetes in youth is increasing in prevalence and appears to be more aggressive in youth compared...
Kosugi, Takaaki et al. | Atherosclerosis 2021; 332(September...
Dyslipidemias are common among patients with chronic kidney disease (CKD) and are a major risk factor...
Fukase, Tatsuya et al. | Atherosclerosis 2021; 333(-): 9-15
Little is known about the long-term impact of apolipoprotein E (apoE) on residual cardiovascular risk...
Ty
Sweeney
et al. | Expert Review of Precision Medicine...
A biomarker is a substance, structure, or process that indicates the presence of a disease, infection,...
JungMin ChoiMD
et al. | The Journal of Clinical Hypertension
...
Hypertension (HTN) is a known leading cause of death and disability over the world. Although lowering...
Andrew C
Martin
et al. | Journal of Paediatrics and Child Health...
Familial hypercholesterolaemia (FH) is a common and preventable genetic cause of premature coronary artery...